Select edition
Country
Primary focus
Medical condition
Organization type
Stakeholder
Quality
Third Edition BOGP (10)
United States (2)
Advocacy (policy advocacy, lobbying)
Neurology/Parkinson's Disease (1)
Medical Device Company (0)
Pharmaceutical companies or industry (incl. Medical device and biotech companies)
Transparency in communication and documentation
Clinical study phase III